SPONTAN Expands Patient Access via National Pharmacy Network
Filed with ASX · · 3 pages · English
Earlier from LTR Pharma
- LTR Signs Collaborative Agreement to Develop OMD Nasal Spray
- Investor Presentation
- Commercial Update and Regulatory Progress
- LTR Pharma to Showcase SPONTAN Data at Urology Conference
- LTR Signs Symbion National Pharmacy Distribution Agreement
Later from LTR Pharma
- Urological Expert Appointed to LTR Scientific Advisory Board
- LTP Completes Extractables Study Milestone for SPONTAN
- SPONTAN 5x Faster Onset Validated in EU Journal
- 18-Month Shelf Life Strengthens SPONTAN Commercialisation
- SPONTAN Case Series - Strong Post-Prostatectomy Results
Follow LTR Pharma into a list and get an email when it puts out news.
Follow LTR Pharma